A First in Human Study of TT5 in Single and Multiple Ascending Doses in Healthy Volunteers and Surgical Patients
Clinical trial NCT06789861 · RECRUITING
Trial details
- NCT number
- NCT06789861
- Sponsor
- Tafalgie Therapeutics
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-23
- Primary completion
- 2026-10-01
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.